CDC director announces her resignation from the agency

President Joe Biden today announced that the director of the U.S. Centers for Disease Control and Prevention, Rochelle Walensky, MD, is resigning from her position. 

Walensky was appointed to the role in December 2020 by President Briden. She replaced Robert Redfield, MD, who served as CDC director throughout most of former President Donald Trump’s administration. Walensky first took over as the post in January 2021 during the widespread rollout of COVID vaccinations in the U.S. 

In a public statement, President Biden thanked Walensky for the “honesty and integrity” she brought to the role amid a pivotal time in the pandemic. 

“Dr. Walensky leaves CDC a stronger institution, better positioned to confront health threats and protect Americans. We have all benefited from her service and dedication to public health, and I wish her the best in her next chapter,” Biden said. 

News of the CDC director’s departure comes on the same day as an announcement made by the World Health Organization declaring the end of the COVID global health emergency. Walensky commented on the development in a letter to President Biden, which was also shared with CDC employees. 

“The end of the COVID-19 public health emergency marks a tremendous transition for our country, for public health, and in my tenure as CDC director,” Walensky wrote. “I took on this role, at your request, with the goal of leaving behind the dark days of the pandemic and moving CDC–and public health–forward into a much better and more trusted place.” 

According to an email sent to CDC employees (shared with CNN) on Friday, May 5, Walensky’s last day will be June 30. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.